InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Smith Karen L., Vice-Président Exécutif et Directeur Médical. Officer active across 6 companies, notably Emergent BioSolutions Inc.. Aggregated, 12 reports have been logged. History available since 7 May 2021. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Smith Karen L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
25,000 shares0Common StockSEC:0001415889-25-017374:0
12,135 shares0Common SharesSEC:0001600620-24-000126:0
17,913 sharesCommon StockSEC:0001600620-24-000114:0
25,000 shares0Common StockSEC:0001415889-24-015762:0
13,900 shares0Common StockSEC:0001209191-23-034407:0
170,354 shares0Common StockSEC:0001209191-22-032677:0
54,193 shares@ US$5.6060.5% of flowCommon StockSEC:0000899243-22-019793:0
24,336 sharesCommon StockSEC:0001209191-22-031508:0
12,500 shares0Common StockSEC:0001209191-22-014157:0
1,622 sharesCommon StockSEC:0001104659-21-142277:0
25,452 shares@ US$4.4224.6% of flowCommon StockSEC:0001209191-21-040340:0
305 shares@ US$60.85100.0% of flowCommon StockSEC:0001367644-21-000081:0
12 of 12 declarations
About Smith Karen L.
Karen L. Smith is EVP, Chief Medical Officer at Emergent BioSolutions Inc., Antares Pharma, Inc., and Acceleron Pharma Inc. She oversees medical and strategic initiatives, playing a key role in product development and innovation.
